» Articles » PMID: 25231630

Thrombin Conducts Epithelial‑mesenchymal Transition Via Protease‑activated Receptor‑1 in Human Gastric Cancer

Overview
Journal Int J Oncol
Specialty Oncology
Date 2014 Sep 19
PMID 25231630
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-mesenchymal transition (EMT) is thought to be a key step for cancer metastasis. Using an immunohistochemical approach with gastric carcinoma tissue, we found the expression of protease-activated receptor-1 (PAR1), along with a metalloproteinase known to activate PAR1, were associated with poorer prognosis, compared with expression-negative tumors, and activated PAR1 promotes gastric cancer cell invasion and proliferation in vivo. In this study we observed EMT induction by the PAR1 agonist α-thrombin, in human gastric cell lines stably expressing PAR1. We investigated α-thrombin-induced changes in the cell forms of pcDNA3.1-MKN45 (MKN45/Mock), pcDNA3.1‑PAR1 transfected MKN45 (MKN45/PAR1), and MKN74. Expression levels of epithelial and mesenchymal markers as well as the distribution of transcriptional factors of E-cadherin in the cytoplasm and nucleus were also noted in these cell lines. We observed α-thrombin-induced morphological changes in MKN45/PAR1 and MKN74 cells. Western blotting and immunohistochemistry of these cells indicated a fall in the expression level of E-cadherin and an increase in fibronectin expression after 48 h. PAR1 activation also induced significant increases in nuclear levels of the Snail which is a repressor of E-cadherin gene expression. We found EMT in gastric cancer cell lines that underwent α-thrombin-induced PAR1 activation.

Citing Articles

Inhibition of Cancer Cell Migration and Invasion In Vitro by Recombinant Tyrosine-Sulfated Haemathrin, A Thrombin Inhibitor.

Jo G, Jung S, Yoon J, Lee J Int J Mol Sci. 2024; 25(21).

PMID: 39519372 PMC: 11546549. DOI: 10.3390/ijms252111822.


Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma.

Pei Q, Li Z, Zhao J, Zhang H, Qin T, Zhao J BMC Biotechnol. 2024; 24(1):55.

PMID: 39135175 PMC: 11318299. DOI: 10.1186/s12896-024-00879-w.


Inhibitory effect of recombinant tyrosine‑sulfated madanin‑1, a thrombin inhibitor, on the behavior of MDA‑MB‑231 and SKOV3 cells .

Jo G, Jung S, Roh T, Yoon J, Lee J Mol Med Rep. 2024; 30(1).

PMID: 38757335 PMC: 11099723. DOI: 10.3892/mmr.2024.13238.


Aptamer-Based Functionalized SERS Biosensor for Rapid and Ultrasensitive Detection of Gastric Cancer-Related Biomarkers.

Shao P, Dong D, Huang Y, Wang Y, Pan L, Zhu Q Int J Nanomedicine. 2023; 18:7523-7532.

PMID: 38106450 PMC: 10723598. DOI: 10.2147/IJN.S434854.


Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.

Hassan M, Shahzadi S, Yasir M, Chun W, Kloczkowski A Sci Rep. 2023; 13(1):18022.

PMID: 37865690 PMC: 10590448. DOI: 10.1038/s41598-023-45347-1.